Motor Neuron Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The laterodorsal nucleus was also particularly affected in genetic cases (28-38%), TDP-43 type A (47%), tau-CBD (44%), and FTD-MND (53%).
|
31696638 |
2020 |
Motor Neuron Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
It has been shown that mutation in FUS and TARDBP are associated with amyotrophic lateral sclerosis(ALS), a motor neuron disease by leading to neuronal cell death.
|
31017923 |
2019 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
TDP-43 aggregation occurs in both familial and sporadic MND; however, the mechanism of endogenous TDP-43 aggregation in disease is incompletely understood.
|
31280399 |
2019 |
Motor Neuron Disease
|
0.200 |
PosttranslationalModification
|
disease |
BEFREE |
Our findings thus link TDP-43 pathology to impaired DSB repair and persistent DDR signaling in motor neuron disease, and suggest that DSB repair-targeted therapies may ameliorate TDP-43 toxicity-induced genome instability in motor neuron disease.
|
30770445 |
2019 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
TIGAR protein was also absent in both TDP-43-positive inclusions in MND and glial cytoplasmic inclusions in MSA.
|
30267647 |
2019 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
TAR DNA-binding protein 43 (TDP-43) aggregation is the most common pathological hallmark in frontotemporal dementia (FTD) and characterizes nearly all patients with motor neuron disease (MND).
|
30511086 |
2019 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
Hyper-phosphorylated and ubiquitinated TDP-43 deposits act as inclusion bodies in the brain and spinal cord of patients with the motor neuron diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD).
|
30837838 |
2019 |
Motor Neuron Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
We describe a case of svPPA associated with MND in the same family, due to a mutation of the transactive response DNA binding protein (TARDBP) gene, and review the literature.
|
30773994 |
2019 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
TDP-43 accumulates in nerve cells of nearly all cases of amyotrophic lateral sclerosis (ALS; the commonest form of motor neuron disease) and in the majority of Tau-negative frontotemporal lobar degeneration (FTLD).
|
29460270 |
2018 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
Additionally, neuronal HuR deficiency resulted in the redistribution of TDP43 to cytosolic granules, which has been linked to motor neuron disease.
|
29760195 |
2018 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
A neuro-pathological examination was performed on 7 patients, and it confirmed the presence of MND with TDP43 protein aggregates in all patients.
|
29886477 |
2018 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
The intrinsically disordered C-terminal domain of TAR DNA-binding protein 43 (TDP-43), a protein involved in motor neuron disease and dementia lacks a dominant LLPS motif, however, and how this domain forms condensates is unclear.
|
29511089 |
2018 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
Frontotemporal dementia (FTD) may be associated with motor neuron disease, and the transactive response DNA-binding protein 43 (TDP-43) is a major pathological substrate underlying both diseases.
|
28449882 |
2017 |
Motor Neuron Disease
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Genetic epidemiology of motor neuron disease-associated variants in the Scottish population.
|
28089114 |
2017 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
We revealed that motor-neuron disease (MND)-linked RNA-binding proteins (RBPs), TDP-43, FUS, and hnRNPA2B1, bind to and induce structural alteration of UGGAA<sub>exp</sub>.
|
28343865 |
2017 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
TDP-43 inclusions in amygdala could be seen in 10 out of 26 sFTLD/MND cases, 5 out of 9 FTLD/MND-C9 cases, and all 4 FTLD-GRN cases.
|
28859337 |
2017 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
All patients with bvFTD + MND or MND showed plentiful p62/TDP-43 positive inclusions in remaining anterior horn cells.
|
26538301 |
2016 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
Defining a cellular signature of aggregated TDP-43 common to nearly all MND and a large proportion of frontotemporal dementia (FTD), has placed MND alongside more traditional cerebral neurodegeneration.
|
27956443 |
2016 |
Motor Neuron Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND), and >95% of familial and sporadic cases involve the deposition of insoluble aggregated, phosphorylated and cleaved TDP-43 protein.
|
27590623 |
2016 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
The concept that frontotemporal dementia (FTD) is a purely cortical dementia has largely been refuted by the recognition of its close association with motor neuron disease, and the identification of transactive response DNA-binding protein 43 (TDP-43) as a major pathological substrate underlying both diseases.
|
25557955 |
2015 |
Motor Neuron Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
A novel mutation P112H in the TARDBP gene associated with frontotemporal lobar degeneration without motor neuron disease and abundant neuritic amyloid plaques.
|
25853458 |
2015 |
Motor Neuron Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Tau (affected by progressive supranuclear palsy or carriers of mutations within the MAPT gene) or TDP-43 (carriers of mutations within granulin, C9orf72, TARDBP genes or affected by FTD with motor neuron disease).
|
25352065 |
2015 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
Frontotemporal lobar degeneration (FTLD) and motor neurone disease are linked by the possession of a hexanucleotide repeat expansion in C9ORF72, and both show neuronal cytoplasmic inclusions within cerebellar and hippocampal neurones which are TDP-43 negative but immunoreactive for p62 and dipeptide repeat proteins (DPR), these being generated by a non-ATG RAN translation of the expanded region of the gene.
|
25185840 |
2015 |
Motor Neuron Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
Together, our results suggest a microtubule-dependent mechanism in motor neuron disease caused by TDP-43-dependent alterations in futsch mRNA localization and translation in vivo.
|
25429138 |
2014 |
Motor Neuron Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
We therefore investigated 33 patients with FTLD-tau (including 9 with MAPT mutation) for TDP-43 pathological changes, and 45 patients with FTLD-TDP (including 12 with hexanucleotide expansion in C9ORF72 and 12 with GRN mutation), and 23 patients with motor neurone disease (3 with hexanucleotide expansion in C9ORF72), for tauopathy.
|
24861427 |
2014 |